Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0001209191-21-040944

Options or other derivatives

  • General Counsel acquired 120,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Winslow Garrett General Counsel 2021-06-15 Grant or award · Stock Option (right to buy) +120,000 120,000 D
Loading xslF345X03/doc4.xml…